CN104983748A - Medicine for treating stomach illness - Google Patents
Medicine for treating stomach illness Download PDFInfo
- Publication number
- CN104983748A CN104983748A CN201510326167.1A CN201510326167A CN104983748A CN 104983748 A CN104983748 A CN 104983748A CN 201510326167 A CN201510326167 A CN 201510326167A CN 104983748 A CN104983748 A CN 104983748A
- Authority
- CN
- China
- Prior art keywords
- medicine
- powder
- tablets
- tablet
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicine for treating stomach illness. The medicine is processed by mixing raw materials, and comprises, by weight, 140 mg-150 mg of metoclopramide tablets, 2200 mg-2500 mg of a furazolidone tablets, 2200 mg-2600 mg of cimetidine tablets, 1650 mg-2100 mg of ranitidine hydrochloride capsules, 16800 mg-18000 mg of yeast tablets and 3600 mg-4000 mg of Yunnan Baiyao powder. When the medicine is prepared, the above raw materials are mixed and polished into powder; and after the powder is qualified through microbiological detection, filling of the powder is carried out in a manner of a capsule. When the medicine is prepared, common Western medicine materials serve as the raw materials, the preparing process is simple, and the production cost is low; the product has the effects of supporting the healthy energy and stopping acid pains and is mainly used for treating the stomach illness such as gastral cavity pains, hyperacidity, congestion and edema which are caused by liver-stomach disharmony; and symptoms such as pains, giddiness, choking sensation in chest and bleeding which are caused by the stomach illness can be reduced.
Description
Technical field
The present invention relates to technical field of pharmaceuticals, specifically a kind of medicine being used for the treatment of gastropathy.
Background technology
Be used for the treatment of in the market gastric ulcer, erosive antral gastritis, gastritis, chronic gastritis, chronic atrophic gastritis, duodenitis, gastrorrhagia, digestive tract hemorrhage the medicine of disease of stomach have a lot, but the curative effect of most drug is not obvious, and the course for the treatment of is long, medicine is unsuitable life-time service also.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of to good effect, and can alleviate the medicine of the treatment gastropathy of gastric disease symptoms.
The present invention solves the problem with following technical scheme:
The present invention treats the medicine of gastropathy, is mixed and processed by following raw material, and the weight proportion of each raw material is as follows:
Metoclopramide Tablets 140mg-150mg, Furazolidone tablet 2200mg-2500mg, cimetidine slice 2200mg-2600mg, ranitidine hydrochloride capsules 1650mg-2100mg, yeast tablet 16800mg-18000mg, YUNNAN BAIYAOFEN 3600mg-4000mg;
Preparation technology: by Metoclopramide Tablets, Furazolidone tablet, cimetidine slice, ranitidine hydrochloride capsules, yeast tablet, YUNNAN BAIYAOFEN, powder is polished into by above-mentioned weight proportion mixing, again after microorganism detection is qualified, finally with capsule form fill.
The present invention adopts common Western medicine medical material as raw material, preparation technology is simple, production cost is low, product has to hold up down and consolidates, antacid pain relieving, be mainly used in treating in the gastralgia caused by incoordination between the liver and stomach, hyperchlorhydria and the gastropathy such as hyperemia, edema, pain that gastropathy causes, the symptom such as dizzy, uncomfortable in chest, hemorrhage can be alleviated.
Detailed description of the invention
The present invention treats the medicine of gastropathy, and be mixed and processed after being polished into powder by following raw material, the weight proportion of each raw material is as follows:
Metoclopramide Tablets 140mg-150mg, Furazolidone tablet 2200mg-2500mg, cimetidine slice 2200mg-2600mg, ranitidine hydrochloride capsules 1650mg-2100mg, yeast tablet 16800mg-18000mg, YUNNAN BAIYAOFEN 3600mg-4000mg.
Composition and effect of formula Raw of the present invention are as follows:
1, Metoclopramide Tablets (can be provided by Shanxi Yun Peng pharmaceutical Co. Ltd): this product Main Ingredients and Appearance is metoclopramide, its chemical name is the chloro-Benzoylamide of N-[(2-lignocaine) ethyl]-4-amino-2-methoxyl group-5-.Molecular formula: C
14h
22clN
3o
2molecular weight: 299.80.Indication is anti-emetic.Be mainly used in: 1. the symptomatic treatment of the symptom such as Nausea and vomiting, belch, dyspepsia, stomach distension, hyperchlorhydria caused by the various cause of disease; 2. reflux esophagitis, bile reflux gastritis, functional gastric retention, gastroptosis etc.; 3. gastric emptying after Delayed gastric emptying disease, Vagus nerve stimulation; 4. gastric emptying disorder caused by the collagen illness such as diabetic gastroparesis, uremia, scleroderma.
2, Furazolidone tablet (can be provided by Shanxi Yun Peng pharmaceutical Co. Ltd): the active ingredient of this product is furazolidone.The chemical name of active ingredient: 3-(contracting of 5-nitryl furfural is amino)-oxazolidones [2] molecular formula: C
8h
7o
5n
3molecular weight: 225.16.Indication is for being mainly used in the bacillary dysentery caused by sensitive organism, and enteritis, cholera, also may be used for typhoid fever, paratyphoid fever, giardiasis, trichomoniasis etc.
3, cimetidine slice (can be provided by Chengdu Jinhua Pharmaceutical Co., Ltd): the Main Ingredients and Appearance of this product is cimetidine, and its chemical name is: N1-methyl-N11-[2 [[(5-methyl isophthalic acid H-imidazol-4 yl) methyl] sulfo-] ethyl]-N-cyano group arc.Molecular formula: C
10h
16n
6s molecular weight: 252.34.Be used for the treatment of duodenal ulcer, gastric ulcer, reflux esophagitis, stress ulcer and Zhuo-Emhorn (Zollinger-Ellison) syndrome.It mainly acts on H on parietal cell
2receptor, plays the effect of competitive inhibition histamine.Can basal gastric acid secretion be suppressed, also can suppress the gastric acid secretion stimulated by food, histamine, pentagastrin, caffeine and insulin etc.
4, ranitidine hydrochloride capsules (can be provided by Golden Horse pharmaceutical factory of Nanning City): the hydrochloric ranitidine of this product every (in ranitidine) 0.15 gram.Adjuvant is: starch.Indication is for for alleviating stomachache caused by hyperchlorhydria, heartburn sense (heartburn), acid regurgitation.This product is H
2acceptor inhibitor, has gastric acid secretion inhibiting effect.Rapid through gastrointestinal absorption after oral.
5, yeast tablet (can be provided by the fine pharmaceutical Co. Ltd in Guangdong): the every sheet of this product is containing Main Ingredients and Appearance dry yeast 0.2 gram, and adjuvant is sucrose, magnesium stearate, aluminium hydroxide.Indication is for malnutrition, dyspepsia, inappetence and vitamin B group deficiency disease.It is the dry thalline of cereuisiae fermentum, is rich in vitamin B group, has auxiliary therapeutic action to dyspepsia.It is faint yellow to light yellowish-brown color chips; Have the special smell of yeast, mildly bitter flavor, do not have foreign odor.
6, YUNNAN BAIYAOFEN (can be provided by Yunnan Paiyao Group Corp., Ltd): indication is removing stasis to stop bleeding, promoting blood circulation and stopping pain, removing toxic substances and promoting subsidence of swelling; For traumatic injury, swelling and pain due to blood stasis, haematemesis, hemoptysis, have blood in stool, hemorrhoidal bleeding, metrostaxis, operative hemorrhage, sore swollen toxin and soft tissue contusion, closed fracture, bronchiectasis and pulmonary tuberculosis hemoptysis, and skin infection disease.This product is the powder of lark to sundown; The special fragrance of tool, taste slightly feels refrigerant, and has numb feeling in the tongue.Insurance is the red spherical or spherical watered pill of class, and section is brown or sepia; Feeble QI, mildly bitter flavor.
During preparation, above-mentioned raw materials mixing is polished into medicated powder, then after microorganism detection is qualified, adopts No. 0 capsule dress, through polishing (thin,tough silk handkerchief), bottling, 0.45 gram every, i.e. obtained finished product.
The using method of medicine of the present invention is: oral.Consumption is: every day 3 times, each 3, within seven days, is a course for the treatment of; Other medicines auxiliary treatment can be coordinated.
Below embodiments of the invention
Embodiment 1:
Composition of raw materials: Metoclopramide Tablets 140mg, Furazolidone tablet 2200mg, cimetidine slice 2200mg, ranitidine hydrochloride capsules 1650mg, yeast tablet 16800mg, YUNNAN BAIYAOFEN 3600mg.
Preparation technology:
By above-mentioned Western medicine and Chinese patent medicine selected after, be polished into powder by the mixing of above-mentioned weight proportion respectively, then after microorganism detection is qualified, adopt No. 0 capsule fill, through polishing (thin,tough silk handkerchief), bottle 63 (0.45 grams every), namely obtain finished product.
Embodiment 2:
Composition of raw materials: Metoclopramide Tablets 145mg, Furazolidone tablet 2300mg, cimetidine slice 2400mg, ranitidine hydrochloride capsules 1800mg, yeast tablet 17200mg, YUNNAN BAIYAOFEN 3800mg.
Preparation technology:
By above-mentioned Western medicine and Chinese patent medicine selected after, be polished into powder by the mixing of above-mentioned weight proportion respectively, then after microorganism detection is qualified, adopt No. 0 capsule fill, through polishing (thin,tough silk handkerchief), bottle 63 (0.45 grams every), namely obtain finished product.
Embodiment 3:
Composition of raw materials: Metoclopramide Tablets 150mg, Furazolidone tablet 2500mg, cimetidine slice 2600mg, ranitidine hydrochloride capsules 2100mg, yeast tablet 18000mg, YUNNAN BAIYAOFEN 4000mg.
Preparation technology:
By above-mentioned Western medicine and Chinese patent medicine selected after, be polished into powder by the mixing of above-mentioned weight proportion respectively, then after microorganism detection is qualified, adopt No. 0 capsule fill, through polishing (thin,tough silk handkerchief), bottle 63 (0.45 grams every), namely obtain finished product.
Below the exemplary authentication example taking product of the present invention:
1, stone X, female, 41 years old, people from Guangxi.Patient is because of " Upper abdominal pain accompanies dyspepsia in more than 2 years ", and to Nanning City, the 7th the People's Hospital checks, it is rotten to the corn that check result is shown as chronic non-atrophic gastritis accompanied body of stomach.After taking 7 days course for the treatment of of product of the embodiment of the present invention 2, pain disappears so far, and appetite increases now, stomach good mood might as well, stomach does not have other uncomfortable yet.
2, beam X, man, 39 years old, people from Guangxi.Patient is because of " hypogastralgia accompanies melena after more than 2 years ", and check to Bose City Tiandong County the People's Hospital, check result is digestive tract hemorrhage.Discharge is handled after hospitalization poor effect.After 7 days course for the treatment of of product of taking the embodiment of the present invention 1, melena stops, and digestive tract is no longer hemorrhage, and lower abdomen still has slightly remaining pain.
3, Liao X, man, 39 years old, people from Guangxi.Patient is because of " hypogastralgia accompanies melena after more than 3 years ", and check to Ping Ma commune hospital, Tiandong County, check result is shown as gastrorrhagia, DeGrain after taking medicine to treat a period of time when institute.After taking 7 days course for the treatment of of the embodiment of the present invention 2 product, melena disappears, continue to take 7 days course for the treatment of of another prescription drug (mixed by Metoclopramide Tablets 155mg, Furazolidone tablet 2500mg, yeast tablet 10600mg and CHENXIANGLU BAILU PIAN 3900mg and be polished into powder) again, after totally two 14 days courses for the treatment of, pain disappears so far.
4, X is opened, man, 21 years old, people from Guangxi.Patient was because of Upper abdominal pain more than 2 years, and be shown as chronic gastritis through People's Liberation Army garrison in Hong Kong's examination in hospital result, shallow is rotten to the corn, in People's Liberation Army garrison in Hong Kong's hospitalize many days, pain was not still alleviated, and can not carry out normal army daily workout; After taking 7 days course for the treatment of of the embodiment of the present invention 1 product, pain obtains obvious alleviation, also can trained.
5, tall and erect X, man, 33 years old, people from Guangxi, patient was because of upper abdominal pain repeatedly more than 1 year; Through Hangzhou, new mountain area the 3rd the People's Hospital checks to suffer from: (1) chronic atrophic gastritis; (2) Helicobacter pylori infection.New mountain area the 3rd the People's Hospital's out-patient treatment less effective in Hangzhou, after it first takes 7 days course for the treatment of of product of the embodiment of the present invention 3, symptom alleviates a lot, after continue to take 7 days course for the treatment of of another prescription drug (mixed by Metoclopramide Tablets 155mg, Furazolidone tablet 2500mg, yeast tablet 10600mg and CHENXIANGLU BAILU PIAN 3900mg and be polished into powder) again, after totally two 14 days courses for the treatment of, so far pain disappears, does not feel there is any discomfort.
6, king X, man, 38 years old, people from Shandong; Patient, because of upper abdominal pain repeatedly more than several years, checks to suffer from gastric ulcer through Tiandong County, Guangxi the People's Hospital.In Tiandong County the People's Hospital, therapeutic effect is not good enough, and the pain of upper abdomen is not still removed; After taking 7 days course for the treatment of of product of example 2 of the present invention, Upper abdominal pain is significantly alleviated; Continue to take 7 days course for the treatment of of another prescription drug (mixed by Metoclopramide Tablets 155mg, Furazolidone tablet 2500mg, yeast tablet 10600mg and CHENXIANGLU BAILU PIAN 3900mg and be polished into powder) again, after totally two 14 days courses for the treatment of, so far Upper abdominal pain disappears, does not feel there is any discomfort.
Claims (1)
1. treat a medicine for gastropathy, it is characterized in that, it is mixed and processed by following raw material, and the weight proportion of each raw material is as follows:
Metoclopramide Tablets 140mg-150mg, Furazolidone tablet 2200mg-2500mg, cimetidine slice 2200mg-2600mg, ranitidine hydrochloride capsules 1650mg-2100mg, yeast tablet 16800mg-18000mg, YUNNAN BAIYAOFEN 3600mg-4000mg;
Preparation technology: by Metoclopramide Tablets, Furazolidone tablet, cimetidine slice, ranitidine hydrochloride capsules, yeast tablet, YUNNAN BAIYAOFEN, powder is polished into by above-mentioned weight proportion mixing, again after microorganism detection is qualified, finally with capsule form fill.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510326167.1A CN104983748A (en) | 2015-06-12 | 2015-06-12 | Medicine for treating stomach illness |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510326167.1A CN104983748A (en) | 2015-06-12 | 2015-06-12 | Medicine for treating stomach illness |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104983748A true CN104983748A (en) | 2015-10-21 |
Family
ID=54295738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510326167.1A Pending CN104983748A (en) | 2015-06-12 | 2015-06-12 | Medicine for treating stomach illness |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104983748A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1091010A (en) * | 1993-02-20 | 1994-08-24 | 王尤理 | A kind of stomach medicine composition-Guoguang stomach medicine |
CN1129107A (en) * | 1995-02-14 | 1996-08-21 | 中国医学科学院肿瘤医院 | Medicinal composition for curing ulcer of upper digestive tract and effectively inhibiting recurrance thereof |
CN1220877A (en) * | 1998-06-08 | 1999-06-30 | 王太营 | Medicine for treatment of stomach disease |
CN102008633A (en) * | 2010-12-22 | 2011-04-13 | 李振国 | Medicinal capsules for treating gastric ulcer, duodenal ulcer and gastritis |
CN102028790A (en) * | 2011-01-05 | 2011-04-27 | 邓安富 | Medicament for treating ulcer of digestive system |
-
2015
- 2015-06-12 CN CN201510326167.1A patent/CN104983748A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1091010A (en) * | 1993-02-20 | 1994-08-24 | 王尤理 | A kind of stomach medicine composition-Guoguang stomach medicine |
CN1129107A (en) * | 1995-02-14 | 1996-08-21 | 中国医学科学院肿瘤医院 | Medicinal composition for curing ulcer of upper digestive tract and effectively inhibiting recurrance thereof |
CN1220877A (en) * | 1998-06-08 | 1999-06-30 | 王太营 | Medicine for treatment of stomach disease |
CN102008633A (en) * | 2010-12-22 | 2011-04-13 | 李振国 | Medicinal capsules for treating gastric ulcer, duodenal ulcer and gastritis |
CN102028790A (en) * | 2011-01-05 | 2011-04-27 | 邓安富 | Medicament for treating ulcer of digestive system |
Non-Patent Citations (3)
Title |
---|
倪根珊编著: "《药物临床应用撷萃》", 31 August 1994, 八一出版社 * |
曾建斌: ""雷尼替丁加云南白药治疗消化性溃疡42例"", 《实用中医药杂》 * |
邹家浩: ""西咪替丁、呋喃唑酮、胃复安治疗小儿消化性溃疡对比研究"", 《河南医药信息》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102106360B (en) | Sucrose-free prebiotic biscuits with function of nursing stomach illness and preparation method thereof | |
US10111451B2 (en) | Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor | |
CN104906540A (en) | Preparation method and application of traditional Chinese medicine ointment for preventing and treating delayed nausea and vomiting caused by chemotherapy | |
CN102125660B (en) | Traditional Chinese medicine sustained-release micro granules stomach and intestine partner for protecting and strengthening functions of stomach and intestine | |
WO2013013498A1 (en) | Chinese medicine beverage for nourishing the heart to calm the mind | |
CN101780246B (en) | Traditional Chinese medicine composition with function of promoting digestion and preparation method thereof | |
CN100431593C (en) | Chinese medicinal formulation for treating hydrocephalus | |
CN104906539B (en) | The Chinese medicine composition of delayed nausea and vomiting and its application caused by a kind of prevention chemotherapy | |
CN104873688A (en) | Drug for curing stomach disease | |
US10646449B2 (en) | Rice bran sterol sugar-coated tablet | |
CN103495080A (en) | Traditional Chinese medicine for treating infantile anorexia | |
CN104983748A (en) | Medicine for treating stomach illness | |
CN104043075A (en) | Traditional Chinese medicine mixture for treatment of spleen-stomach dampness and coldness | |
CN101450195A (en) | Traditional Chinese medicine composition for treating stomach cold | |
CN100450494C (en) | Medicinal use of Aralia continentalis kitag | |
CN103784665B (en) | Alleviate Chinese medicine preparation of irritable bowel syndrome and preparation method thereof | |
CN1977866B (en) | Poria weight-losing agent | |
CN104324070A (en) | External and orally-taken drug for treating ulcer disease and preparation method of external and orally-taken drug | |
CN1935244A (en) | Health care tea for promoting digestion, invigorating spleen and promoting appetite | |
CN100337681C (en) | Gastric ulcer treating medicine | |
CN101890158A (en) | Prescription and preparation method of mixture for tonifying stomach and promoting digestion | |
WO2010092467A1 (en) | Medicament comprising terpenoid cholinesterase inhibitor for treatment of dismotility disorder | |
CN102205085B (en) | Anti-ulcer powder for treating stomach disease | |
CN113908241A (en) | Method for preparing Chinese herbal medicine pill | |
CN103961632A (en) | Traditional Chinese medicinal composition for treating gastric ulcer and duodenal ulcer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151021 |